Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1
A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder
β Scribed by Y. Lecrubier; A. J. Puech; A. Azcona; P. E. Bailey; X. Lataste
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 594 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In a double-blind controlled study lasting 8 weeks, 50 anxious psychoneurotic outpatients with a primary diagnosis of generalized anxiety or panic disorder were randomly assigned to alprazolam (n = 30), a new benzodiazepine, or placebo (n = 20), after a washout period of 1 week. Alprazolam at dosage
## Abstract ## Objective To assess the efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder (GAD). ## Methods Acuteβphase data from a subset of patients (β₯65 years) with GAD were pooled from four randomized, doubleβblind, placeboβcontrolled trials of dulo